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Abstract: Cohesin complex components exert fundamental roles in animal cells, both canonical in
cell cycle and non-canonical in gene expression regulation. Germline mutations in genes coding
for cohesins result in developmental disorders named cohesinopaties, of which Cornelia de Lange
syndrome (CdLS) is the best-known entity. However, a basic description of mammalian expression
pattern of cohesins in a physiologic condition is still needed. Hence, we report a detailed analysis of
expression in murine and human tissues of cohesin genes defective in CdLS. Using both quantitative
and qualitative methods in fetal and adult tissues, cohesin genes were found to be ubiquitously
and differentially expressed in human tissues. In particular, abundant expression was observed in
hematopoietic and central nervous system organs. Findings of the present study indicate tissues
which should be particularly sensitive to mutations, germline and/or somatic, in cohesin genes.
Hence, this expression analysis in physiological conditions may represent a first core reference
for cohesinopathies.
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1. Introduction
The structure of the cohesin complex has been well described in all metazoa, showing a high
degree of conservation in the number of components, protein structure and assembly dynamics [1–3].
On the other hand, complex functions have been increasingly unraveled. The canonical function
was first described in the budding yeast, Saccharomyces cerevisiae [4–7] and was later confirmed in all
studied organisms, including mammals [8]. This function is essential for cell division, as cohesins
hold sister chromatids together until anaphase, when the mitotic spindle separates DNA content in
daughter cells.
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Subsequently, two additional functions, termed “non-canonical” have been put forward. The
first highlighted an essential role for the cohesin complex in DNA repair, both by homologous
recombination and check-point induction [9,10]. The second, by which the cohesin ring intervenes
in gene expression regulation both by three-dimensional chromatin folding and RNA polymerase
recruitment, grounded on in vivo genetic data on Drosophila melanogaster and genome-wide studies in
fly cultured cells [11] and was then confirmed in vertebrate models [12].
Mutations in members of the cohesin complex have been associated with genetic developmental
disorders with intellectual disability named cohesinopathies, of which Cornelia de Lange syndrome
(CdLS) is the most frequent and best known entity [13,14]. CdLS is a malformative syndrome affecting
many organs, including central nervous system, gastrointestinal and musculoskeletal [15] CdLS is
genetically heterogeneous (CdLS1 MIM 122470, CdLS2 MIM 300590, CdLS3 MIM 610759, CdLS4
MIM 614701, CdLS5 MIM 300882), with a broad clinical expressivity and up to 80% of cases carry
heterozygous autosomal or X-linked mutations in one of cohesin complex components/regulators:
SMC1A, SMC3, RAD21, NIPBL, HDAC8 [16].
In the last decade, various organisms (fruit fly, zebrafish and mouse) have been used for
modeling cohesionopathies and functional studies have highlighted the extensive transcriptional
dysregulation caused by different CdLS pathogenic variants [17–19]. Surprisingly, a basic description
of the mammalian expression pattern of the main CdLS causative genes in physiologic condition is
still missing. Hence, for better forwarding the challenge of clinical observations and interpretation of
the models-phenotype correlations, here we report a detailed analysis of expression in murine and
human tissues of the cohesin genes which are defective in CdLS.
2. Results
2.1. Cohesin Genes Are Ubiquitously and Differentially Expressed in Human Tissues
NIPBL, SMC1A, SMC3, RAD21 and HDAC8 expression was detected in all analyzed fetal (liver
and brain) and adult tissues (heart, lung, kidney, adrenal gland, salivary gland, trachea, small intestine,
stomach, thyroid, spleen, thymus, brain, cerebellum, bone marrow and peripheral blood). Expression
analysis was normalized using two different tissues (heart and adrenal gland) as calibrator and the
same results were obtained. In particular, the expression profile varied across the five genes and for
each of them across different organs. Figures S1 and S2, and Table S1 provide the results normalized
on heart. Kidney and respiratory tract showed scarce expression for all cohesin subunits/regulator
genes whereas the gastrointestinal tract showed robust gene expression levels. All genes share
high or peak expression levels in hematopoietic and cerebellum (see next sections). The global
expression profiling of the five genes was comparable in all tissues, with the exception of NIPBL
which showed the highest expression levels. Comparing our results with data publicly available
(https://www.ebi.ac.uk/gxa/home), although expressed in different units and obtained with other
techniques and less detailed, the trend of expression was comparable (Tables S2–S6). Interestingly,
organs frequently affected in CdLS patients showed abundant expression of causative cohesin genes
(Table S7).
2.2. Cohesins Expression Is Intense in Hematopoietic Tissues
All human hematopoietic tissues analyzed—fetal liver, thymus, spleen, bone marrow, and
peripheral blood- displayed high levels of NIPBL, SMC1A, SMC3, RAD21 and HDAC8 expression.
In particular, the spleen showed the most abundant levels, ranging from 20 folds (HDAC8) to 200
folds—NIPBL—increased expression. On the other hand, an opposite expression pattern was observed
in the fetal liver, whereas HDAC8 and RAD21 showed the lowest levels of expression in the peripheral
blood (Figure 1).
Using spleens from adult wild-type mice, Nipbl and Smc1a distribution was assessed by in situ
hybridization on paraffin sections. The expression of both genes could be visualized in spleen follicles
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of wild-type animals as positively stained cells. Nipbl expression appears scattered in the follicles
(Figure 1A,B), rich in lymphocytes, whereas Smc1a seems to localize especially in the germinative area
of the follicle (Figure 1C,D).
Figure 1. Cohesin expression in hematopoietic tissues. Histograms (E–I) show NIPBL, SMC1A, SMC3,
HDAC8 and RAD21 gene expression levels in fetal liver, thymus, spleen, bone marrow and peripheral
blood as 2−∆∆Ct. In situ hybridization on 10 micron-sections of (A,B) lower and higher magnification
and (C,D). Both genes are expressed in spleen follicles of wild-type animals as positively stained cells.
Nipbl expression appears scattered in the follicles, rich in lymphocytes (A,B), whereas Smc1a (C,D)
localizes particularly in the germinative area of the follicle.
2.3. Cohesins Are Differentially Expressed in Bone Marrow Cells
Gene expression analysis in FACS-sorted bone marrow cell subpopulations revealed a dynamic
cell-specific expression. In particular, the genes for cohesin complex SMC1A core subunit, NIPBL
loading factor and HDAC8 regulator, are expressed in all cell types, including KIT-positive progenitor
cells, B cells, T cells and myeloid population, with differences among genes and among cells
(Figure 2). Nevertheless, for all analyzed genes, the myeloid compartment exhibited the most abundant
expression, where the relatively most abundant gene is SMC1A, compared to both HDAC8 and NIPBL.
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Figure 2. Analysis of bone marrow cell subpopulations. (A–D) FACS cell sorting analysis of
subpopulations was achieved with specific antibodies recognizing c-KIT/CD117 (correspondent
to multipotent progenitor cells), myeloid cell antigens (antibodies mix anti-CD15 and anti-CD33),
CD3 (to select T lymphocytes) and CD19 to detect B lymphocytes, respectively. As a hierarchical
gating strategy, the four cell subsets were selected on CD45 positive population, which represents
a pan-leukocyte antigen, to identify white blood cells. Dot plots of dimensional scatters (FSC and
SSC) are shown, in addition to sorting gates, P3 (myeloid cells), P4 (B cells), P5 (precursors) and P6
(T cells). Histograms (E–G) show SMC1A core subunit, NIPBL loading factor and HDAC8 regulator
gene expression as 2−∆∆Ct in stem cells (cKIT+), T cells, B cells and myeloid cells. Error bars represent
standard deviation. Asterisks indicate statistically significant values: * p ≤ 0.05; ** p ≤ 0.005.
2.4. Cohesins Are Differentially Expressed in Central Nervous System Tissues
All cohesins were found to be expressed in brain, cerebellum and fetal brain, with NIPBL, SMC1A,
SMC3 and HDAC8 highly expressed in the cerebellum (Figure 3). Analysis of mouse developing brain
by in situ hybridization of Nipbl revealed a dynamic pattern of expression at different developmental
stages (Figures 3 and 4 and Table S8). Smc1a expression was similar to Nipbl in showing gene
expression distribution augmenting with developmental age in all fetal tissues, especially at the
level of hindbrain-derived neural structures, such as pons, medulla oblongata, choroid plexuses
and cerebellum.
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Figure 3. Cohesin expression in the central nervous system. (A) In situ hybridization on 10
micron-sections of 17.5 dpc (days post coitum) mouse fetus, revealed Nipbl expression as dynamic in
the fetal CNS. Structures found positive for Nipbl expression are shaded in blue. (B–F) Histograms
show NIPBL, SMC1A, SMC3, HDAC8 and RAD21 gene expression levels in human fetal brain and
human adult brain and cerebellum as 2−∆∆Ct.
Figure 4. Nipbl and Smc1a expression is modulated during development. In situ hybridization on 10
micron-sections of 13.5 dpc (days post coitum) (A,B), 15.5 dpc (C,D) mouse fetuses, revealed Nipbl and
Smc1a expression as dynamic during development. Structures where Nipbl and Smc1a were found to be
expressed are in blue.
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3. Discussion
CdLS is a rare mendelian developmental intellectual disability disorder characterized by genetic
heterogeneity and variable severity of adverse phenotype, caused by mutations in genes coding
for the cohesin complex. Notwithstanding the multiple functions of the cohesin complex in the
fundamental processes of chromosome segregation and post-replicative DNA repair [5,9], a large
body of evidence has fostered the current assumption that defect in the “non-canonical function”
of regulation of gene expression is the main driving pathomechanism of cohesinopathies [10,20–23].
Several pathways with a known fundamental role in development have been found to be disrupted in
cohesinopathies models [19,21,24–26]. However, a clear description of quantitative expression and
pattern of the cohesin genes in adult and fetal tissues from control subjects is a relevant premise to seek
for associations of altered pathways with clinical features underpinning the variable phenotype within
and across CdLS subentities. Prompted by the scarce data in the literature, we sought to analyze the
transcripts of the cohesin complex genes which mutations underlie CdLS subtypes, to assess their
levels and distribution across different tissues. Quantitative RT-PCR analysis evidenced a ubiquitous,
although differential expression of the cohesin genes. In particular, we found cohesins expressed not
only in tissues with intense proliferative activity and renewal turnover (such as the bone marrow
and the peripheral blood), in keeping with the canonical role of this complex, but also in tissues
with modest or absent cell proliferation such as the nervous system, as previously reported also in
D. melanogaster [27].
As regards the sustained expression of all cohesin genes in the bone marrow, which has been
deepened by assays on specific FACS-sorted bone marrow cell populations, we consider it may
also reflect the cohesin role in controlling pluripotency factors. Indeed, the cohesin complex has
been shown to regulate the adult hematopietic “stem cells pool” and it has been proposed as a
master regulator of transcriptional cascade in hematopoiesis [28]. Accordingly, cohesin loss leads
to myeloproliferative neoplasms in mice, outlining a tumor suppressing function for the cohesin
complex in vivo [29]. The cohesin complex with the zing finger DNA-binding protein CTCF and
Mediator have been identified as key players of chromatin loop organization [25,30]. Interestingly a
contribution of cohesins, and Mediator to DNA looping specific of murine embryonic stem cells has
been demonstrated by their interactions and co-occupancy of enhancer and core promoter regions of a
set of genes active in ES (embryonic stem) cells, such as the pluripotency Oct4, Sox2, Nanog genes [25].
Cohesin genes are highly expressed in the myeloid compartment and this data is consistent with
increasing evidences of cohesin somatic mutations in myeloid leukemia [31,32].
Moreover, in vivo modeling using D. rerio has demonstrated how rad21 controls runx1, a master
controller of hematopoiesis during embryogenesis [33,34]. RUNX1 has been shown to play a pivotal
role in maintenance of homeostasis of hematopoietic stem and progenitor cells in mammals [35].
Aberrant expression of RUNX1 is known to cause myeloid leukemia and since the first report in
2010 [36] a number of studies have shown somatic mutations in the cohesin complex as responsible
for myeloid leukemia [32]. Consistently, differential expression of Nipbl and Smc1a was found in
mouse spleen.
Moving to another likely relevant tissue/compartment, we showed that both fetal and adult
cerebellum samples consistently express high levels of cohesin complex genes. As during adult life,
the proliferative cells in this organ are limited, the non-canonical role of cohesin is postulated to be
prominent in this district. Only a few indications of cerebellum-specific clinical findings emerge from
the literature on cohesinopathies models and human patients [37]. Out of these, in D. rerio, both smc1a
and nipblb haploinsufficiency result in abnormalities of the hindbrain, the embryonic precursor of
the cerebellum [24,26] and it is interesting that out of the structures found to express cohesins during
development, the majority were hindbrain-derived (as pons, medulla oblongata and choroid plexus).
CdLS patients do not normally present ataxia, however few reports on abnormalities of hindbrain
derived structures have been published [38]. On the other hand, cerebellar hypoplasia is often
found in syndromic patients, but the pathogenetic impact is still debated. Many studies have
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reported pathological findings in the cerebellum of patients diagnosed with autism and autism
spectrum disorders, and cerebellum hypoplasia has also been correlated with non-syndromic delayed
psychomotor development. It is worth noting that autistic features, such as repetitive behavior and
expressive communication deficits, are often present in a subset of CdLS patients [39], bridging a
monogenic and a multifactorial neurodevelopmental disorder. The clinical correlation is not yet
validated, hence further studies should monitor anatomical abnormalities in the brain of CdLS patients
aiming at better evaluating the clinical relevance of this data.
4. Materials and Methods
4.1. Human Tissues
For a detailed analysis of gene expression, RNA from a commercially available biobank was used
(Human Total Master Plan II, Clontech, Mountain View, CA, USA). Tissues were derived from healthy
subjects, both males and females. In addition, total bone marrow (BM) cells from a single subject were
collected, after permission by signed inform consent of healthy donor to donate leftover material from
clinical procedures for research purposes. Ethics approval number 1739, approved by San Gerardo
Hospital ethics committee on the 27 June 2013. Viable mononuclear cells were collected from the
bone marrow of a healthy donors and purified by Ficoll-Paque density gradient (GE Healthcare Life
Sciences, Marlborough, MA, USA), according to manufacturer’s protocol.
4.2. Antibodies and Flow Cytometry
Peridinin chlorphyll protein (PerCP) anti CD45 (pan-leukocyte antigen), phycoerythrin-
conjugated antibodies anti-CD117 (for precursors), fluorescein isothiocyanate- conjugated (FITC)
anti-CD15 and anti-CD33 (for myeloid cells), Texas Red conjugated anti-CD3 (for T-lymphocytes)
and allophycocyanin-cyanin7-conjugated (APC-Cy7) anti-CD19 (for B-lymphocytes) were used for
sorting (BD Biosciences, Milan, Italy). Staining of healthy donor BM cells was performed in standard
conditions, and sorting was performed using FACSAria (BD Biosciences). Data were analyzed using
FACS Diva Software (v8.0.1, BD Biosciences).
4.3. Animals
All mouse experiments were performed as previously described [24] and under the regulations,
licenses and local ethical review from Queen Mary University of London (PPL license 70/8269)
following UK Home Office Animals (Scientific Procedures) Act 1986. Briefly, C57bl6 females were
bred with males of the same strain at the end of the daily light cycle and checked for vaginal plugs the
following morning. The day of the vaginal plug was considered as embryonic age 0.5 dpc (days post
coitum). Pregnant females were then sacrificed by cervical dislocation at desired gestational age for
collecting embryos.
4.4. In Situ Hybridization
Expression analysis by in situ hybridization was performed as previously described [24]. Briefly,
paraffin sections of different stages embryos and fetuses were deparaffinized and hybridized overnight
with Nipbl and Smc1a mouse DIG-labelled (Roche, Basel, Switzerland) anti-sense probes as reported.
4.5. Reverse-Transcription PCR and Real-Time Quantitative-PCR Assays
RNA was either available in the biobank or extracted from bone marrow and peripheral blood cells
of healthy individuals with TRIZOL (Sigma, Mendota Heights, MN, USA) following manufacturer’s
protocol. Superscript II enzyme (Thermo Fisher Scientific, Waltham, MA, USA) was used for cDNA
synthesis. Quantitative RT-PCR experiments were performed as previously described [26] using Light
Cycler 480 II with Universal Probe Master system (Roche, Basel, Switzerland). Primers and probes
were selected according to the Software Probe Finder (Roche, Basel, Switzerland) and are reported in
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Table S9. Assays (primers and UPL probe matching) were designed using the dedicated UPL probe
finder software v2.52 (release on 5 March 2017), available at Universal ProbeLibrary Assay Design
Center (https://qpcr.probefinder.com). The coding alternative isoform transcripts contemporarily were
selected, when present. Assays were then confirmed with the new software release v2.53 (release on
25 June 2017, database update: h_sap-Ensembl v89_38). In Table S9, we report the correspondent gene
accession numbers, included in design and annotated in Nucleotide database (NCBI). The recognized
amplicons were analyzed with the two genome browsers BLAST (https://blast.ncbi.nlm.nih.gov)
and UCSC (https://genome.ucsc.edu/) respectively, confirming that these assays are specific (not
recognizing unspecific or redundant targets) and detect all the protein coding transcript. ABL1 gene
was used as reference [40,41]. Four independent replicates were performed for each assay. Data
have been shown as fold change, calculated as 2−∆∆Ct using the progenitor fraction (c-KIT+) as the
calibrator sample (2−∆∆Ct = 1) [40]. For quantitative RT-PCR, data were statistically analyzed applying
a two-tailed t-test setting p ≤ 0.05 as significant and indicated with symbol *.
5. Conclusions
In conclusion, the overall findings here presented point to tissues which should be particularly
sensitive to the defects in cohesin genes, starting from crucial developmental windows, to postnatal
life when the mantainance of those tissues homeostasis is required. This expression data may represent
a first core reference to decode and interpret clinical findings displayed by patients with different
CdLS subtypes.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/2/
438/s1.
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